IGF1 and cancer: There are several lines of long‐standing evidence linking higher serum levels of IGF1 (associated with increased growth) and decreased serum levels of some IGFBPs (associated with suppressing growth through binding IGF1) with additional cancer risk (reviewed in Crowe et al., 2011).